Full Text
Full text is available in PDF
Prothrombin, Factor-V Leiden, and Plasminogen Activator Inhibitor Type 1 Gene Polymorphisms in Hemodialysis Patients with/without Arteriovenous Fistula Thrombosis
1Erciyes University, Medical Faculty, Department of Medical Genetics, eliffunda@erciyes.edu.tr, TURKEY
2Department of Medical Genetics, Erciyes University Medical School, Turkey
*Corresponding Author: Erciyes University, Medical Faculty, Department of Medical Genetics, eliffunda@erciyes.edu.tr, TURKEY. Email: eliffunda@erciyes.edu.tr
Published online:Apr 30, 2010
Article type:Research Article
Received:Jul 08, 2009
Accepted:Aug 27, 2009
Abstract
Background and Aims: Factor V Leiden mutation (G1691A) has been recognized to be the most prevalent genetic risk factor for venous thrombosis. Other common risk factor for venous thrombosis is Prothrombin 20210 G-A alteration, which causes a gain of function in the coagulation system with an increase of prothrombin levels, associated with an increased potential to form thrombin. Plasminogen activator inhibitor type 1 (PAI-1) 4G/5G polymorphism is the most frequently studied in thrombotic events. Aim of this study was to investigate the relationship between these polymorphisms and arteriovenous fistula (AVF) thrombosis in hemodialysis (HD) patients.
Methods: The study included 31 HD patients with AVF thrombosis and 51 HD patients without AVF thrombosis. DNA was extracted from peripheral blood samples from the patient and control groups. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods were used to identify the polymorphisms.
Results: There were no significant differences between HD patients with and without AVF thrombosis in terms of Factor V Leiden and Prothrombin G20210A mutations. PAI-1 4G allele in heterozygous state have an effect on the thrombosis risk in HD patients (O.R= 4.271).
Conclusions: Only carrying PAI-1 4G/5G genotype had an additional risk for thrombosis in HD patients.
Highlights
How to Cite:Emirogullari E, Saatci C, Unal A, Sahin A, Ozkul1 Y. Prothrombin, Factor-V Leiden, and Plasminogen Activator Inhibitor Type 1 Gene Polymorphisms in Hemodialysis Patients with/without Arteriovenous Fistula Thrombosis. Nephro-Urol Mon. 2010;2(2):. doi:
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
31
Jan
2010
Alternatively Spliced Human Tissue Factor and Thrombotic Tendencies in Hemodialysis Patients
Susan Zawaski,
Mary Hammes,
Viji Balasubramanian
Zawaski S, Hammes M, Balasubramanian V. Alternatively Spliced Human Tissue Factor and Thrombotic Tendencies in Hemodialysis Patients. Nephro-Urol Mon. 2010;2(1):. doi:
31
Mar
2010
The protective effect of FXIII Val34Leu polymorphism against deep vein thrombosis: a report from Iranian Blood Transfusion Organization (IBTO)
SM Sajadi,
S Samiei,
M Kheyrandish,
MH Ahmadi,
Z Ataee
Sajadi S, Samiei S, Kheyrandish M, Ahmadi M, Ataee Z. The protective effect of FXIII Val34Leu polymorphism against deep vein thrombosis: a report from Iranian Blood Transfusion Organization (IBTO). J Inflamm Dis. 2024;13(4):e155500. doi:
26
Dec
2015
Correlation Between C677T and A1298C Mutations on the MTHFR Gene With Plasma Homocysteine Levels and Venous Thrombosis in Pregnant Women at Risk of Thrombosis
Kazem Ghaffari,
Ali Ghasemi,
Abbas Ghotaslou,
Mohsen Mohammadi,
Zeynal Salmanpour
Ghaffari K, Ghasemi A, Ghotaslou A, Mohammadi M, Salmanpour Z. Correlation Between C677T and A1298C Mutations on the MTHFR Gene With Plasma Homocysteine Levels and Venous Thrombosis in Pregnant Women at Risk of Thrombosis. Zahedan J Res Med Sci. 2015;17(12):e5192. doi: https://doi.org/10.17795/zjrms-5192
31
Oct
2010
The Effect of Antiplatelet Drugs on the Patency Rate of Arterio-venous Fistulae in Hemodialysis Patients
Mohsen Rouzrokh,
Mohammad Reza Abbasi,
Ali Reza Mirshemirani,
Mohammad Reza Sobhiyeh
Rouzrokh M, Abbasi MR, Mirshemirani AR, Sobhiyeh MR. The Effect of Antiplatelet Drugs on the Patency Rate of Arterio-venous Fistulae in Hemodialysis Patients. Iran J Pharm Res. 2010;9(4):e126072. doi: https://doi.org/10.22037/ijpr.2010.913
30
Jun
2013
Native Arterio-Venous Fistula Is the Vascular Access of Choice for Hemodialysis in End Stage Renal Disease
Farooq Ahmad Ganie,
Hafeezulla Lone,
Abdul Majeed Dar,
Ghulam Nabi Lone,
Mohd Lateef Wani
Ahmad Ganie F, Lone H, Majeed Dar A, Nabi Lone G, Wani ML. Native Arterio-Venous Fistula Is the Vascular Access of Choice for Hemodialysis in End Stage Renal Disease. Int Cardiovasc Res J. 2013;7(2):e12706. doi:
Cited by
- Scopus by DOI: 0
Last Update: 4 days ago
- Scopus by Title: 0
Last Update: 4 days ago
- Scopus by Title (Ref): 9
Last Update: 4 days ago
- CrossRef: 0
Last Update: 4 days ago
- OpenAlex: 0
Last Update: 2 days ago
- OpenCitations: 0
Last Update: 1 day ago
Comments
Number of Comments:0Indexed in
